$9.56
0.111.16%
In chiusura: Nov 21, 4:00 PM EST
$9.56
N/A
After hour: Nov 21, 4:00 PM EST
Comments
Loading...
Stime degli utili, EPS e fatturato
Amicus Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
feb 18
Stima EPS
$0.130
Stima dei ricavi trimestrali
$179.73M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$598.70M
Analizza lo storico degli utili di Amicus Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
FOLD | Amicus Therapeutics | $0.09 | $0.13 | — | — | $149.71M | $179.73M | — | — | 02/18/2026 | |
FOLD | Amicus Therapeutics | $0.10 | $0.09 | $0.17 | 88.89% | $141.52M | $165.33M | $169.06M | 2.26% | 11/04/2025 | |
FOLD | Amicus Therapeutics | $0.06 | -$0.01 | $0.01 | 200.00% | $126.67M | $147.01M | $154.69M | 5.22% | 07/31/2025 | |
FOLD | Amicus Therapeutics | -$0.02 | $0.08 | $0.03 | -62.50% | $110.40M | $136.35M | $125.20M | -8.18% | 05/01/2025 | |
FOLD | Amicus Therapeutics | $0.01 | $0.09 | $0.09 | 0.00% | $115.08M | $147.87M | $149.71M | 1.24% | 02/19/2025 | |
FOLD | Amicus Therapeutics | -$0.01 | $0.00 | $0.10 | 100.00% | $103.50M | $135.33M | $141.52M | 4.57% | 11/06/2024 | |
FOLD | Amicus Therapeutics | -$0.07 | -$0.05 | $0.06 | 220.00% | $94.50M | $121.43M | $126.67M | 4.31% | 08/08/2024 | |
FOLD | Amicus Therapeutics | -$0.06 | -$0.07 | -$0.02 | 71.43% | $86.27M | $111.19M | $110.40M | -0.71% | 05/09/2024 | |
FOLD | Amicus Therapeutics | -$0.19 | -$0.06 | $0.01 | 116.67% | $88.10M | $114.33M | $115.08M | 0.65% | 02/28/2024 | |
FOLD | Amicus Therapeutics | -$0.12 | -$0.08 | -$0.07 | 12.50% | $81.69M | $101.36M | $103.50M | 2.11% | 11/08/2023 | |
FOLD | Amicus Therapeutics | -$0.21 | -$0.12 | -$0.15 | -25.00% | $80.73M | $89.87M | $94.50M | 5.16% | 08/08/2023 | |
FOLD | Amicus Therapeutics | -$0.30 | -$0.15 | -$0.18 | -20.00% | $78.72M | $83.08M | $86.27M | 3.84% | 05/10/2023 | |
FOLD | Amicus Therapeutics | -$0.29 | -$0.13 | -$0.19 | -46.15% | $82.15M | $86.29M | $88.10M | 2.09% | 03/01/2023 | |
FOLD | Amicus Therapeutics | -$0.19 | -$0.19 | -$0.12 | 36.84% | $79.55M | $84.22M | $81.69M | -3.00% | 11/07/2022 | |
FOLD | Amicus Therapeutics | -$0.19 | -$0.22 | -$0.21 | 4.55% | $77.41M | $85.89M | $80.73M | -6.01% | 08/04/2022 | |
FOLD | Amicus Therapeutics | -$0.25 | -$0.25 | -$0.30 | -20.00% | $66.40M | $77.13M | $78.72M | 2.05% | 05/09/2022 | |
FOLD | Amicus Therapeutics | -$0.27 | -$0.16 | -$0.29 | -81.25% | $70.57M | $83.28M | $82.15M | -1.35% | 02/24/2022 | |
FOLD | Amicus Therapeutics | -$0.22 | -$0.18 | -$0.19 | -5.56% | $67.44M | $80.11M | $79.55M | -0.71% | 11/09/2021 | |
FOLD | Amicus Therapeutics | -$0.20 | -$0.22 | -$0.19 | 13.64% | $62.35M | $73.36M | $77.41M | 5.52% | 08/05/2021 | |
FOLD | Amicus Therapeutics | -$0.35 | -$0.24 | -$0.25 | -4.17% | $60.52M | $71.65M | $66.40M | -7.32% | 05/10/2021 | |
FOLD | Amicus Therapeutics | -$0.35 | -$0.23 | -$0.27 | -17.39% | $55.29M | $70.06M | $70.57M | 0.73% | 03/01/2021 |
Amicus Therapeutics (FOLD) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $0.17 | $0.09 | 88.9 % |
| Q2 | 2025-07-31 | $0.01 | $-0.01 | 200.0 % |
| Q1 | 2025-05-01 | $0.03 | $0.08 | -62.5 % |
| Q4 | 2025-02-19 | $0.09 | $0.09 | 0.00 % |
Amicus Therapeutics (FOLD) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $169.06M | $165.33M | 2.26 % |
| Q2 | 2025-07-31 | $154.69M | $147.01M | 5.22 % |
| Q1 | 2025-05-01 | $125.20M | $136.35M | -8.18 % |
| Q4 | 2025-02-19 | $149.71M | $147.87M | 1.24 % |
FAQ
Quando Amicus Therapeutics (NASDAQ:FOLD) riporterà gli utili?
Si prevede che Amicus Therapeutics (FOLD) fornisca risultati il febbraio 18, 2026. Gli ultimi risultati sono stati pubblicati il novembre 4, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Amicus Therapeutics (NASDAQ:FOLD)?
L'EPS effettivo era $0.17, che superato la stima di $0.09.
Quali sono state le entrate di Amicus Therapeutics (NASDAQ:FOLD)?
Le entrate effettive sono state $169.1M, che superato la stima di $165.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.